Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-12-010409)

Filing Details

Accession Number:: 0001127602-12-010409
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-03-12 17:16:13
Reporting Period:: 2012-03-08

Filing Date:: 2012-03-12
Accepted Time:: 2012-03-12 17:16:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
97745	Thermo Fisher Scientific Inc.	TMO	Measuring & Controlling Devices, Nec (3829)	042209186

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1108494	E Michael Porter	81 Wyman Street Waltham MA 02451		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-03-08	3,750	$26.53	18,390	No	4	M	Direct
Common Stock	Disposition	2012-03-08	3,750	$56.05	14,640	No	4	S	Direct
Common Stock	Acquisiton	2012-03-09	3,750	$26.53	18,390	No	4	M	Direct
Common Stock	Disposition	2012-03-09	2,694	$56.41	15,696	No	4	S	Direct
Common Stock	Disposition	2012-03-09	756	$56.42	14,940	No	4	S	Direct
Common Stock	Disposition	2012-03-09	300	$56.43	14,640	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-03-08	3,750	$0.00	3,750	$26.53
Common Stock	Stock Option (Right to Buy)	Disposition	2012-03-09	3,750	$0.00	3,750	$26.53

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
3,750		2012-05-17	No	4	M	Direct
0		2012-05-17	No	4	M	Direct

Footnotes

The option originally was to have vested in three equal annual installments beginning on May 17, 2006, but became fully exercisable on November 9, 2006, as a result of the Issuer's merger with Fisher Scientific International Inc..